Substance / Medication

Sacrosidase

Overview

Active Ingredient
sacrosidase
RxNorm CUI
214817

Indications

® Sucraid(sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.

Labeler: QOL Medical, LLCUpdated: 2025-12-29T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Sucraid is contraindicated in patients known to be hypersensitive to yeast, yeast products, glycerin (glycerol), or papain (see WARNINGS).

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

19 trials linked to this intervention

19
Total Trials
7
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Congenital and putatively acquired forms of sucrase-isomaltase deficiency in infancy: effects of sacrosidase therapy.
Lücke Thomas, Keiser Markus, Illsinger Sabine et al. · J Pediatr Gastroenterol Nutr · 2009
PMID: 19680155Case Report
Invertase is an effective and cost-efficient alternative to sacrosidase oral solution for sucrase deficiency: a cohort study.
Morris Jennifer, Moreland Eve, Wands David I F et al. · Arch Dis Child · 2025
PMID: 40216532Other
13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients.
Robayo-Torres Claudia C, Opekun Antone R, Quezada-Calvillo Roberto et al. · J Pediatr Gastroenterol Nutr · 2009
PMID: 19330928OtherFull text (PMC)
Sacrosidase.
Am J Health Syst Pharm · 2001
PMID: 11794951Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sacrosidase (substance)
SNOMED CT
108962007
UMLS CUI
C0718043
RxNorm CUI
214817
Labeler
QOL Medical, LLC

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
19
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.